{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:06:10Z","timestamp":1793815570195,"version":"4.6.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Preclinical studies from our laboratory demonstrated therapeutic effects of enteral dextrose administration in the acute phase of sepsis, mediated by the intestine-derived incretin hormone glucose-dependent insulinotropic peptide. The current study investigated the effects of an early enteral dextrose infusion on systemic inflammation and glucose metabolism in critically ill septic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Single-center, double-blind, placebo-controlled randomized pilot clinical trial (NCT03454087).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Tertiary-care medical center in Pittsburgh, PA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Critically ill adult patients within 48 hours of sepsis diagnosis and with established enteral access.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>Participants were randomized 1:1 to receive a continuous water (placebo) or enteral dextrose infusion (50% dextrose; 0.5\u2009g\/mL) at 10\u2009mL per hour for 24 hours.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We randomized 58 participants between June 2018 and January 2020 (placebo: <jats:italic toggle=\"yes\">n<\/jats:italic> = 29, dextrose: <jats:italic toggle=\"yes\">n<\/jats:italic> = 29). Protocol adherence was high with similar duration of study infusion in the placebo (median duration, 24\u2009hr [interquartile range, 20.9\u201324 hr]) and dextrose (23.9\u2009hr [23\u201324 hr]) groups (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.59). The primary outcome of circulating interleukin-6 at end-infusion did not differ between the dextrose (median, 32 pg\/mL [19\u201379 pg\/mL]) and placebo groups (24 pg\/mL [9\u201359 pg\/mL]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.13) with similar results in other measures of the systemic host immune response. Enteral dextrose increased circulating glucose-dependent insulinotropic peptide (76% increase; 95% CI [35\u2013119]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01) and insulin (53% [17\u201388]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01) compared with placebo consistent with preclinical studies, but also increased blood glucose during the 24-hour infusion period (153\u2009mg\/dL [119\u2013223] vs 116 mg\/dL [91\u2013140]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01). Occurrence of emesis, ICU and hospital length of stay, and 30-day mortality did not differ between the placebo and enteral dextrose groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Early infusion of low-level enteral dextrose in critically ill septic patients increased circulating levels of insulin and the incretin hormone glucose-dependent insulinotropic peptide without decreasing systemic inflammation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000550","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T18:08:24Z","timestamp":1633716504000},"page":"e550","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis"],"prefix":"10.1097","volume":"3","author":[{"given":"Faraaz Ali","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios D.","family":"Kitsios","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Yende","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Department of Critical Care Medicine, Pittsburgh, PA."},{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Dunlap","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Scholl","sequence":"additional","affiliation":[{"name":"VA Pittsburgh Healthcare System, Department of Critical Care Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Chuan","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nameer","family":"Al-Yousif","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingze","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehdi","family":"Nouraie","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"McVerry","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA."},{"name":"Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA."},{"name":"Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607115621863","article-title":"Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).","volume":"40","author":"McClave","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJMoa1102662","article-title":"Early versus late parenteral nutrition in critically ill adults.","volume":"365","author":"Casaer","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1001\/jama.2013.5124","article-title":"Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: A randomized controlled trial.","volume":"309","author":"Doig","year":"2013","journal-title":"JAMA"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00134-017-4711-6","article-title":"The intensive care medicine research agenda in nutrition and metabolism.","volume":"43","author":"Arabi","year":"2017","journal-title":"Intensive Care Med"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1210\/jc.2019-00296","article-title":"Therapeutic effects of endogenous incretin hormones and exogenous incretin-based medications in sepsis.","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP.","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action.","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s10753-014-9919-9","article-title":"Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.","volume":"37","author":"Lee","year":"2014","journal-title":"Inflammation"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acs.biomac.5b01756","article-title":"Trimeric PEG-conjugated exendin-4 for the treatment of sepsis.","volume":"17","author":"Lee","year":"2016","journal-title":"Biomacromolecules"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12035-016-0307-3","article-title":"Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice.","volume":"55","author":"Neves","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/CCM.0b013e3181d9d87a","article-title":"Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia.","volume":"38","author":"Deane","year":"2010","journal-title":"Crit Care Med"},{"key":"R13-20240807","first-page":"37","article-title":"Exogenous glucagon-like peptide-1 attenuates glucose absorption and reduces blood glucose concentration after small intestinal glucose delivery in critical illness.","volume":"19","author":"Miller","year":"2017","journal-title":"Crit Care Resusc"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.11.001","article-title":"Stimulation of the endogenous incretin glucose-dependent insulinotropic peptide by enteral dextrose improves glucose homeostasis and inflammation in murine endotoxemia.","volume":"193","author":"Shah","year":"2018","journal-title":"Transl Res"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"E2901","DOI":"10.3390\/nu12102901","article-title":"Physiologic effects of exogenous dextrose in murine Klebsiella pneumoniae sepsis vary by route of provision.","volume":"12","author":"Chuan","year":"2020","journal-title":"Nutrients"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jpen.1608","article-title":"Rationale for and design of the study of early enteral dextrose in sepsis: A pilot placebo-controlled randomized clinical trial.","volume":"44","author":"Shah","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"Suppl 3","key":"R19-20240807","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.2337\/diabetes.53.suppl_3.S220","article-title":"Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.","volume":"91","author":"Nauck","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"R21-20240807","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","article-title":"Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.","volume":"34","author":"Holst","year":"2011","journal-title":"Diabetes Care"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","article-title":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: Evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.","volume":"165","author":"Meduri","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20240807","first-page":"E43","article-title":"Effect of propofol continuous-rate infusion on intravenous glucose tolerance test in dogs.","volume":"5","author":"Maeda","year":"2018","journal-title":"Vet Sci"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000201231","article-title":"Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.","volume":"56","author":"Herrmann","year":"1995","journal-title":"Digestion"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/acem.12015","article-title":"Hyperlactatemia affects the association of hyperglycemia with mortality in nondiabetic adults with sepsis.","volume":"19","author":"Green","year":"2012","journal-title":"Acad Emerg Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/CCM.0000000000001650","article-title":"Admission hyperglycemia in critically ill sepsis patients: Association with outcome and host response.","volume":"44","author":"van Vught","year":"2016","journal-title":"Crit Care Med"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc11301","article-title":"Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients.","volume":"16","author":"Nakamura","year":"2012","journal-title":"Crit Care"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.","volume":"37","author":"Falciglia","year":"2009","journal-title":"Crit Care Med"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"e0248853","DOI":"10.1371\/journal.pone.0248853","article-title":"Association of the systemic host immune response with acute hyperglycemia in mechanically ventilated septic patients.","volume":"16","author":"Farooq","year":"2021","journal-title":"PLoS One"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNFalpha and TNF receptors in obesity and insulin resistance.","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J Intern Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.","volume":"110","author":"Maedler","year":"2002","journal-title":"J Clin Invest"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3748\/wjg.v9.i8.1824","article-title":"Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations.","volume":"9","author":"Yu","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"e0134427","DOI":"10.1371\/journal.pone.0134427","article-title":"Degradation and stabilization of peptide hormones in human blood specimens.","volume":"10","author":"Yi","year":"2015","journal-title":"PLoS One"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1378\/chest.107.4.1062","article-title":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.","volume":"107","author":"Meduri","year":"1995","journal-title":"Chest"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.","volume":"25","author":"Whitehead","year":"2016","journal-title":"Stat Methods Med Res"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41430-020-00750-z","article-title":"Statistical analysis of continuous outcomes from parallel-arm randomized controlled trials in nutrition-a tutorial.","volume":"75","author":"Ritz","year":"2021","journal-title":"Eur J Clin Nutr"},{"key":"R38-20240807","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jclinepi.2006.02.007","article-title":"ANCOVA versus change from baseline: More power in randomized studies, more bias in nonrandomized studies [corrected].","volume":"59","author":"Van Breukelen","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/biomet\/73.3.751","article-title":"An improved Bonferroni procedure for multiple tests of significance.","volume":"73","author":"Simes","year":"1986","journal-title":"Biometrika"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1097\/CCM.0000000000004018","article-title":"Host-response subphenotypes offer prognostic enrichment in patients with or at risk for acute respiratory distress syndrome.","volume":"47","author":"Kitsios","year":"2019","journal-title":"Crit Care Med"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc7874","article-title":"The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: A randomised double-blind placebo-controlled cross over study.","volume":"13","author":"Deane","year":"2009","journal-title":"Crit Care"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/SHK.0000000000000153","article-title":"Abandon the mouse research ship? Not just yet!","volume":"41","author":"Osuchowski","year":"2014","journal-title":"Shock"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13613-019-0543-6","article-title":"Preclinical septic shock research: Why we need an animal ICU.","volume":"9","author":"Guillon","year":"2019","journal-title":"Ann Intensive Care"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R45-20240807","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jpen.1706","article-title":"Phase 3 pilot randomized controlled trial comparing early trophic enteral nutrition with \u201cno enteral nutrition\u201d in mechanically ventilated patients with septic shock.","volume":"44","author":"Patel","year":"2020","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/CCM.0000000000000035","article-title":"The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: A pilot study.","volume":"42","author":"Galiatsatos","year":"2014","journal-title":"Crit Care Med"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccc.2018.11.011","article-title":"Incretin physiology and pharmacology in the intensive care unit.","volume":"35","author":"Plummer","year":"2019","journal-title":"Crit Care Clin"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/cc9983","article-title":"Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.","volume":"15","author":"Deane","year":"2011","journal-title":"Crit Care"},{"key":"R49-20240807","doi-asserted-by":"crossref","first-page":"e0209669","DOI":"10.1371\/journal.pone.0209669","article-title":"Permissive underfeeding, cytokine profiles and outcomes in critically ill patients.","volume":"14","author":"Arabi","year":"2019","journal-title":"PLoS One"},{"key":"R50-20240807","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0148607111433054","article-title":"Markers of inflammation and coagulation may be modulated by enteral feeding strategy.","volume":"36","author":"Bastarache","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R51-20240807","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccm.2016.01.011","article-title":"Metabolism, metabolomics, and nutritional support of patients with sepsis.","volume":"37","author":"Englert","year":"2016","journal-title":"Clin Chest Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:07:18Z","timestamp":1723043238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000550","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}